Bioage Labs Inc stock is traded at $5.54, with a volume of 673,141. It is down -6.89% in the last 24 hours and down -12.89% over the past month. Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
Previous Close:
$5.95
Open:
$5.93
24h Volume:
673,141
Relative Volume:
0.84
Market Cap:
$254.27M
Revenue:
$10.32M
Net Income/Loss:
-$89.93M
P/E Ratio:
-
EPS:
-$2.41
Net Cash Flow:
-$88.63M
1W Performance:
-6.73%
1M Performance:
-12.89%
6M Performance:
-66.79%
1Y Performance:
-26.13%
1-Day Range:
$5.45$6.02
1-Week Range:
$5.45$6.30
52-Week Range:
$4.81$25.96
Bioage Labs Inc Stock (BIOA) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS